Company registration number 10752335 (England and Wales)
IMPETUS PHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2026
IMPETUS PHARMA LIMITED
COMPANY INFORMATION
Director
Mrs LC Burbidge
Company number
10752335
Registered office
Garthwaite
Crawley Hill
West Wellow
United Kingdom
SO51 6AP
Accountants
Xeinadin
First Floor Secure House
Lulworth Close
Chandler's Ford
Eastleigh
Hampshire
England
SO53 3TL
IMPETUS PHARMA LIMITED
CONTENTS
Page
Accountants' report
1
Profit and loss account
2
Balance sheet and notes to the financial statements
3 - 4
IMPETUS PHARMA LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF IMPETUS PHARMA LIMITED FOR THE YEAR ENDED 31 MAY 2026
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Impetus Pharma Limited for the year ended 31 May 2026, which comprise the profit and loss account and the balance sheet, from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Impetus Pharma Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Impetus Pharma Limited and state those matters that we have agreed to state to the board of directors of Impetus Pharma Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Impetus Pharma Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Impetus Pharma Limited has kept adequate accounting records and to prepare statutory financial statements that comply with the requirements of the Companies Act 2006. You consider that Impetus Pharma Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Impetus Pharma Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Xeinadin
First Floor Secure House
Lulworth Close
Chandler's Ford
Eastleigh
Hampshire
SO53 3TL
England
9 October 2026
IMPETUS PHARMA LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MAY 2026
- 2 -
2026
2025
£
£
Turnover
181,476
141,554
Other income
111
21
Staff costs
(74,697)
(53,901)
Depreciation and other amounts written off assets
(2,597)
(3,098)
Other charges
(8,535)
(11,934)
Tax
(19,700)
(13,929)
Profit
76,058
58,713
IMPETUS PHARMA LIMITED
BALANCE SHEET
AS AT
31 MAY 2026
31 May 2026
- 3 -
2026
2025
£
£
£
£
Fixed assets
7,793
9,296
Current assets
255,511
201,365
Prepayments and accrued income
11,770
-
0
Creditors: amounts falling due within one year
(42,856)
(21,377)
Net current assets
224,425
179,988
Total assets less current liabilities
232,218
189,284
Net assets
232,218
189,284
Capital and reserves
232,218
189,284
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2026
2025
Number
Number
Employees
1
1

Impetus Pharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is Garthwaite, Crawley Hill, West Wellow, United Kingdom, SO51 6AP.

For the year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

IMPETUS PHARMA LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MAY 2026
31 May 2026
- 4 -
The financial statements were approved and signed by the director and authorised for issue on 9 October 2026
Mrs LC Burbidge
Director
Company registration number 10752335 (England and Wales)
2026-05-312025-06-01falsefalseCCH SoftwareCCH Accounts Production 2026.200No description of principal activityMrs LC Burbidgefalse107523352025-06-012026-05-3110752335bus:Director12025-06-012026-05-3110752335bus:RegisteredOffice2025-06-012026-05-31107523352026-05-31107523352024-06-012025-05-31107523352025-05-3110752335core:CurrentFinancialInstrumentscore:WithinOneYear2026-05-3110752335core:CurrentFinancialInstrumentscore:WithinOneYear2025-05-3110752335bus:PrivateLimitedCompanyLtd2025-06-012026-05-3110752335bus:Micro-entities2025-06-012026-05-3110752335bus:AuditExemptWithAccountantsReport2025-06-012026-05-3110752335bus:FullAccounts2025-06-012026-05-31xbrli:purexbrli:sharesiso4217:GBP